SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings
Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于股票交易异常波动的公告 | 2026-05-07 | Chinese | |
| 保留意见审计报告的专项说明 | 2026-04-29 | Chinese | |
| 关于独立董事独立性情况的专项意见 | 2026-04-29 | Chinese | |
| 2025年年度审计报告 | 2026-04-29 | Chinese | |
| 公司股票交易可能被实施退市风险警示的风险提示性公告 | 2026-04-29 | Chinese | |
| 2025年度内部控制自我评价报告 | 2026-04-29 | Chinese |
Browse filings by year
27 years- 2026 31 filings
- 2025 140 filings
- 2024 153 filings
- 2023 126 filings
- 2022 127 filings
- 2021 105 filings
- 2020 149 filings
- 2019 183 filings
- 2018 132 filings
- 2017 169 filings
- 2016 162 filings
- 2015 187 filings
- 2014 102 filings
- 2013 133 filings
- 2012 90 filings
- 2011 75 filings
- 2010 84 filings
- 2009 78 filings
- 2008 65 filings
- 2007 67 filings
- 2006 80 filings
- 2005 48 filings
- 2004 46 filings
- 2003 45 filings
- 2002 23 filings
- 2001 6 filings
- 1998 3 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44269811 | 关于股票交易异常波动的公告 | 2026-05-07 | Chinese | ||
| 42005114 | 保留意见审计报告的专项说明 | 2026-04-29 | Chinese | ||
| 42005112 | 关于独立董事独立性情况的专项意见 | 2026-04-29 | Chinese | ||
| 42005094 | 2025年年度审计报告 | 2026-04-29 | Chinese | ||
| 42004793 | 公司股票交易可能被实施退市风险警示的风险提示性公告 | 2026-04-29 | Chinese | ||
| 42004791 | 2025年度内部控制自我评价报告 | 2026-04-29 | Chinese | ||
| 42004789 | 关于2026年度日常关联交易预计的公告 | 2026-04-29 | Chinese | ||
| 42004785 | 关于追认对外财务资助及担保事项的公告 | 2026-04-29 | Chinese | ||
| 42004779 | 董事局审计委员会关于2025年度非标准财务报表审计意见和非标准内部控制审计意见涉及事项专项说明的意见 | 2026-04-29 | Chinese | ||
| 42004775 | 公司营业收入扣除情况表专项核查报告 | 2026-04-29 | Chinese | ||
| 42004771 | 2025年年度报告 | 2026-04-29 | Chinese | ||
| 42004760 | 关于2025年年度报告及2026年第一季度报告预约披露时间变更的公告 | 2026-04-28 | Chinese | ||
| 42004734 | 关于新增累计诉讼、仲裁情况的公告 | 2026-04-24 | Chinese | ||
| 34822837 | 2026年第二次临时股东会决议公告 | 2026-04-17 | Chinese | ||
| 34820475 | 北京德恒（深圳）律师事务所关于深圳市海王生物股份有限公司2026年第二次临时股东会的法律意见 | 2026-04-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53592/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53592 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53592 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53592 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53592}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD (id: 53592)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.